Journal
CHINESE CHEMICAL LETTERS
Volume 29, Issue 6, Pages 899-902Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cclet.2017.09.035
Keywords
New Delhi metallo-beta-lactmase-1; Isatin-beta-thiosemicarbazones; In vitro enzyme inhibition; Molecular docking
Categories
Funding
- 111 Project of Ministry of Education of China [B06005]
- National Natural Science Foundation of China [21672114]
- National Basic Research Program of China [2013CB734004]
Ask authors/readers for more resources
New Delhi metallo-beta-lactmase-1 (NDM-1) catalyzes the hydrolysis of beta-lactam antibiotics and cleaves the p-lactam ring of the molecule, conferring bacterial resistance against these medicines. In an effort to discover novel agents to treat this superbug, an old drug methisazone was found to be a weak NDM-1 inhibitor, with an IC50 of 297.6 mu mol/L. Based on this result, a series of isatin-beta-thiosemicarbazones (IBTs) were synthesized and biologically evaluated as novel NDM-1 inhibitors. Nine of the IBT compounds showed IC50 values of <10 mu mol/L, the best of which was 2.72 mu mol/L. Comparative field analysis (CoMFA) contour maps were generated to depict the structural features and molecular docking was performed to understand the possible binding mode of these inhibitors. The present research hereby has provided valuable information for further discovery of NDM-1 inhibitors. (C) 2017 Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available